IVERIC BIO INC's ticker is ISEE and the CUSIP is 46583P102. A total of 130 filers reported holding IVERIC BIO INC in Q2 2021. The put-call ratio across all filers is 0.37 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $3,265,000 | -39.6% | 517,445 | -40.9% | 1.71% | -41.6% |
| Q1 2021 | $5,409,000 | -2.2% | 875,180 | +9.4% | 2.92% | -31.0% |
| Q4 2020 | $5,528,000 | -58.5% | 800,000 | -66.1% | 4.23% | -69.5% |
| Q3 2020 | $13,323,000 | -4.6% | 2,362,240 | -13.8% | 13.86% | -48.8% |
| Q2 2020 | $13,972,000 | +57.2% | 2,739,641 | +6.0% | 27.06% | +187.9% |
| Q1 2020 | $8,888,000 | -65.5% | 2,583,786 | -13.9% | 9.40% | -47.6% |
| Q4 2019 | $25,740,000 | +500.7% | 3,000,000 | -21.6% | 17.94% | +331.4% |
| Q3 2019 | $4,285,000 | -19.9% | 3,825,903 | -7.0% | 4.16% | +13.0% |
| Q2 2019 | $5,348,000 | – | 4,113,522 | – | 3.68% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TCG Crossover Management, LLC | 5,141,118 | $110,071,336 | 19.43% |
| Deep Track Capital, LP | 7,878,119 | $168,670,528 | 7.08% |
| Soleus Capital Management, L.P. | 2,114,728 | $45,276,326 | 6.50% |
| MPM BioImpact LLC | 1,059,688 | $22,687,920 | 5.89% |
| Finepoint Capital LP | 707,600 | $15,150 | 4.90% |
| ACUTA CAPITAL PARTNERS, LLC | 360,500 | $7,718,305 | 4.75% |
| Octagon Capital Advisors LP | 1,278,000 | $27,361,980 | 4.26% |
| Artia Global Partners LP | 504,615 | $10,803,807 | 4.12% |
| Ghost Tree Capital, LLC | 450,000 | $9,635,000 | 4.11% |
| Redmile Group, LLC | 4,502,111 | $96,390,197 | 3.94% |